tryptoline has been researched along with Acute Confusional Senile Dementia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goyal, B; Goyal, D; Narang, SS | 1 |
| Fokin, VV; Govitrapong, P; Jiaranaikulwanitch, J; Vajragupta, O | 1 |
2 other study(ies) available for tryptoline and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Inhibition of Alzheimer's amyloid-β
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Aspartic Acid Endopeptidases; Carbolines; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; Neurodegenerative Diseases; Peptide Fragments; Triazoles | 2020 |
From BACE1 inhibitor to multifunctionality of tryptoline and tryptamine triazole derivatives for Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Aspartic Acid Endopeptidases; Binding Sites; Biological Assay; Carbolines; Chelating Agents; Humans; Models, Molecular; Protease Inhibitors; Protective Agents; Triazoles; Tryptamines | 2012 |